CTOs on the Move


 
TNS is a Troutdale, OR-based company in the Business Services sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

1st St. NW Inc

1st St. NW Inc is a Saint Paul, MN-based company in the Business Services sector.

Stephenson Printing

Stephenson Printing is a Alexandria, VA-based company in the Business Services sector.

Silicon Spirit Consulting Group, Inc.

Silicon Spirit is a premier business and IT consulting firm to the government, financial services, and the telecommunications sector. Silicon Spirit combines its keen awareness of client business drivers coupled with a proven software methodology from Silicon Spirits Center of Excellence (SSCOE) to ensure its 100 percent on time and on budget delivery record. With its origins in Silicon Valley, Silicon Spirit specializes in Digital Transformation services by applying Low Code Automation, API, RPA, and AI technologies in Cloud based Agile environments. Here is a list of our detailed offerings: CIO Advisory services --Digital Xformation Strategy --API Management and Governance Strategy --Enterpise AI and RPA Strategy -- Digital Transformation Roadmap --AI and RPA Center of Excellence(COE) Creation --Enterprise Agile Adoption Architecture & Development services --Enterprise Architecture --Solution Architecture --Low Code Automation and application development --AI/Machine Learning Model Development Silicon Spirit is also an Appian partner and can help with the following Appian Services --Appian Low Code Automation and RPA jumpstart: Sprint 0 and Beyond --Appian Architectural Consulting --Appian Low Code and RPA Application Development

Oculis

Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.

MITY Enterprises

MITY Enterprises, Inc. designs, manufactures and markets institutional furniture. The Company's product lines include multipurpose room furniture and healthcare seating. Its line of multipurpose room furniture is sold both domestically and